Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John S Sullivan

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2014
Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model miceEthan A Winkler, Jesse D Sengillo, Abhay P Sagare, et al.
Clinical and Vaccine Immunology : CVI|October 5, 2007
High prevalence of the CD14-159CC genotype in patients infected with severe acute respiratory syndrome-associated coronavirusFang F Yuan, Ingrid Boehm, Paul K S Chan, et al.
Journal of Virology|September 29, 2006
CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cellsJohn J Zaunders, Wayne B Dyer, Mee Ling Munier, et al.
The Journal of Infectious Diseases|November 20, 2004
Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementiaMelissa Churchill, Jasminka Sterjovski, Lachlan Gray, et al.
Virology|December 31, 2002
Comprehensive analyses of a unique HIV-1-infected nonprogressor reveal a complex association of immunobiological mechanisms in the context of replication-incompetent infectionBin Wang, Wayne B Dyer, John J Zaunders, et al.
Nature Immunology|August 4, 2009
HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduitsWeifeng Xu, Paul A Santini, John S Sullivan, et al.
Retrovirology|September 25, 2007
Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivoPaul R Gorry, Dale A McPhee, Erin Verity, et al.
Nature Neuroscience|March 3, 2015
GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degenerationEthan A Winkler, Yoichiro Nishida, Abhay P Sagare, et al.
Journal of Virus Eradication|June 14, 2019
Possible clearance of transfusion-acquired <i>nef</i>/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotypeJohn Zaunders, Wayne B Dyer, Melissa Churchill, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2014
Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model miceEthan A Winkler, Jesse D Sengillo, Abhay P Sagare, et al.
Clinical and Vaccine Immunology : CVI|October 5, 2007
High prevalence of the CD14-159CC genotype in patients infected with severe acute respiratory syndrome-associated coronavirusFang F Yuan, Ingrid Boehm, Paul K S Chan, et al.
Journal of Virology|September 29, 2006
CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cellsJohn J Zaunders, Wayne B Dyer, Mee Ling Munier, et al.
The Journal of Infectious Diseases|November 20, 2004
Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementiaMelissa Churchill, Jasminka Sterjovski, Lachlan Gray, et al.
Virology|December 31, 2002
Comprehensive analyses of a unique HIV-1-infected nonprogressor reveal a complex association of immunobiological mechanisms in the context of replication-incompetent infectionBin Wang, Wayne B Dyer, John J Zaunders, et al.
Nature Immunology|August 4, 2009
HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduitsWeifeng Xu, Paul A Santini, John S Sullivan, et al.
Retrovirology|September 25, 2007
Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivoPaul R Gorry, Dale A McPhee, Erin Verity, et al.
Nature Neuroscience|March 3, 2015
GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degenerationEthan A Winkler, Yoichiro Nishida, Abhay P Sagare, et al.
Journal of Virus Eradication|June 14, 2019
Possible clearance of transfusion-acquired <i>nef</i>/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotypeJohn Zaunders, Wayne B Dyer, Melissa Churchill, et al.
Pageof 4